# First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/first-line-erlotinib-followed-by-second-line-cisplatin-gemcitabine-chemotherapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Cesare Gridelli,Fortunato Ciardiello,Ciro Gallo,Ronald Feld,Charles Butts,Vittorio Gebbia,Paolo Maione,Floriana Morgillo,Giovenzio Genestreti,Adolfo Favaretto,Natasha B. Leighl,Rafal Wierzbicki,Saverio Cinieri,Yasmin Alam,Salvatore Siena,Giampaolo Tortora,Raffaella Felletti,Ferdinando Riccardi,Gianfranco Mancuso,Antônio Rossi,Flavia Cantile,Ming‐Sound Tsao,Mauro Saieg,Gilda da Cunha Santos,Maria Carmela Piccirillo,Massimo Di Maïo,Alessandro Morabito,Francesco Perrone |
| Citations | 234 |
| DOI | 10.1200/jco.2011.41.2056 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.41.2056?role=tab |
| OpenAlex ID | https://openalex.org/W2128278369 |
| PMID | 22778317 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Antônio Rossi](https://scholariq.org/researchers/antonio-rossi/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.